Mr Samuel Moussa

Montreal (Canada)

Follow

Contributor content

Mavacamten effectiveness and safety in the real-world setting and association with CYP2C19 metaboliser status: data from a canadian prospective registry

Presentation

Mavacamten effectiveness and safety in the real-world setting and association with CYP2C19 metaboliser status: data from a canadian prospective registry

ESC 365 is supported by

novartis

Explore sponsored resources